Another point of note from the briefing - The new flowsheet allows for 6-9 month evaporation times with HIGHER recoveries and FEWER reagents.This obviously has great flow-on effects on costs and resource life.
Webinar: What investors should know about what it takes for ASX-listed companies to get medical developments to market